Cannabix Technologies makes “50 B.C. Innovations to Watch List” with Marijuana Breathalyzer, Added to CSE25 Index
November 14 2017 - 08:00AM
Cannabix Technologies Inc. (CSE:BLO) (OTC PINK:BLOZF) (the “Company
or Cannabix”), developer of the Cannabix Marijuana Breathalyzer for
law enforcement and the workplace, is pleased to report that the
Company has been listed as one of the “50 Innovations to Watch” in
British Columbia by Business in Vancouver (“BIV”) magazine.
According to BIV, the special edition magazine, “lists 50 made in
B.C. innovations that are making waves across the province, the
country and the world.” The list includes companies from a
wide range of industries such as technology, financial services,
clean tech and consumer products, and includes prominent B.C.
companies like Lululemon Athletica, Ballard Power Systems, and Mogo
Finance. BIV is a leading B.C. business magazine, the link to the
special edition magazine is:
https://www.biv.com/magazine/innovate-2017
The Company also reports that Cannabix Technologies (CSE:BLO)
has qualified for the Canadian Securities Exchange 25 Index (known
as the CSE25 Index) as one of the twenty-five largest companies in
the CSE Composite Index.
The CSE25 Index is a subgroup of the CSE Composite Index. The
composite index launched in 2015 and includes almost half of the
exchange’s listed companies and covers over 75% of the trading
activity on the exchange. The new index includes the top
twenty-five securities by market capitalization contained in the
composite index. These companies account for over 50% of the
weighting in the larger index and are typically stocks that attract
considerable trading volume.
About Cannabix Technologies Inc
Cannabix Technologies Inc. is a leader in marijuana breathalyzer
development for law enforcement and the workplace. Cannabix has
established breath testing technologies in the pursuit of bringing
durable, portable hand-held tools to market to enhance detection of
marijuana impaired driving offences on roads at a time when
marijuana is becoming legal in many global jurisdictions. Cannabix
is working to develop drug-testing devices that will detect THC-
the psychoactive component of marijuana that causes intoxication-
using breath samples. In particular, Cannabix is focused on
developing breath testing devices for detection of recent use of
THC, in contrast to urine testing for THC metabolite that requires
an invasive collection and reflects use days or even weeks earlier.
The devices will also be useful for other practical applications
such as testing employees in the workplace where intoxication by
THC can be hazardous.
We seek Safe Harbor.
On behalf of the Board of Directors
“Rav Mlait”
CEOCannabix Technologies Inc.
For further information, contact the Company at
info@cannabixtechnologies.com
The CSE has not reviewed and does not accept responsibility for
the adequacy or accuracy of this release.
Cautionary Statement Regarding Forward-Looking Statements This
press release contains forward-looking information that involves
various risks and uncertainties regarding future events. Such
forward-looking information can include without limitation
statements based on current expectations involving a number of
risks and uncertainties and are not guarantees of future
performance of the Company, such as final development of a
commercial or prototype product(s), successful trial or pilot of
company technologies, no assurance that commercial sales of any
kind actually materialize; no assurance the Company will have
sufficient funds to complete product development. There are
numerous risks and uncertainties that could cause actual results
and the Company’s plans and objectives to differ materially from
those expressed in the forward-looking information, including: (i)
adverse market conditions; (ii) risks regarding protection of
proprietary technology; (iii) the ability of the Company to
complete financings; (iv) the ability of the Company to develop and
market its future product; and (v) risks regarding government
regulation, managing and maintaining growth, the effect of adverse
publicity, litigation, competition and other factors which may be
identified from time to time in the Company's public announcements
and filings. There is no assurance that the marijuana breathalyzer
business will provide any benefit to the Company, and no assurance
that any proposed new products will be built or proceed. There is
no assurance that existing “patent pending” technologies licensed
by the Company will receive patent status by regulatory
authorities. The Company is not currently selling commercial
breathalyzers. Actual results and future events could differ
materially from those anticipated in such information. These and
all subsequent written and oral forward-looking information are
based on estimates and opinions of management on the dates they are
made and are expressly qualified in their entirety by this notice.
Except as required by law, the Company does not intend to update
these forward-looking statements.
Cannabix Technologies Inc.7934 Government Road, Burnaby, B.C.,
V5A 2E2Phone: (604) 551-7831Fax:
604-676-2767info@cannabixtechnologies.com cannabixtechnologies.com
Cannabix Technologies (CSE:BLO)
Historical Stock Chart
From Feb 2024 to Mar 2024
Cannabix Technologies (CSE:BLO)
Historical Stock Chart
From Mar 2023 to Mar 2024